Skip to main content
OSCR logo

OSCR · Oscar Health, Inc. · Webcasts, Transcripts & Audio

Track OSCR — free
$31.05 -0.89 (-2.79%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript
Market Cap
$9.65B
Shares
310.69M
Volume · Nov 13 4.85M Avg daily vol (3M) 5.27M

Oscar Health, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Oscar Health, Inc. (OSCR), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Earnings call
FY26 · Q3
2026-11-05
Oscar Health, Inc. (OSCR) Q3 2026 Earnings Call Transcript
Confident tone Pricing and market morbidity CMS eligibility and program integrity Record financial performance
Revenue
$5.14B
▲ 72.1% YoY
Diluted EPS
$0.49
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2026-08-06
Oscar Health, Inc. (OSCR) Q2 2026 Earnings Call Transcript
Confident tone Record profitability and financial performance Product innovation and member navigation Operating leverage and cost discipline
Revenue
$4.88B
▲ 70.4% YoY
Diluted EPS
$1.10
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-08
Oscar Health, Inc. (OSCR) June 8, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-06
Oscar Health, Inc. (OSCR) Q1 2026 Earnings Call Transcript
Confident tone Risk adjustment and metal mix Individual market dynamics Q1 financial performance
Revenue
$4.65B
▲ 52.6% YoY
Diluted EPS
$2.07
▲ 125% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-10
Oscar Health, Inc. (OSCR) Q4 2025 Earnings Call Transcript
Confident tone ICRA and defined contribution strategy Membership growth and market share MLR and market morbidity
Revenue
$2.81B*
▲ 17.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Oscar Health, Inc. (OSCR) Q3 2025 Earnings Call Transcript
Positive tone 2025 Financial Results and 2026 Profitability Outlook Higher Market Morbidity and Risk Adjustment Membership Growth and Geographic Expansion
Revenue
$2.99B
▲ 23.2% YoY
Diluted EPS
$-0.53
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-06
Oscar Health, Inc. (OSCR) Q2 2025 Earnings Call Transcript
Balanced tone 2025 financial results and guidance ICHRA growth strategy and acquisitions Market morbidity shift
Revenue
$2.86B
▲ 29% YoY
Diluted EPS
$-0.89
▼ 545% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-07
Oscar Health, Inc. (OSCR) Q1 2025 Earnings Call Transcript
Confident tone Medical loss ratio and risk adjustment Top-line growth and membership SG&A efficiency
Revenue
$3.05B
▲ 42.2% YoY
Diluted EPS
$0.92
▲ 48.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-04
Oscar Health, Inc. (OSCR) Q4 2024 Earnings Call Transcript
Confident tone Medical loss ratio and pricing discipline Record financial performance and profitability milestones Above-market growth in individual ACA market
Revenue
$2.39B*
▲ 67.1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Oscar Health, Inc. (OSCR) Q3 2024 Earnings Call Transcript
Confident tone Medical Loss Ratio (MLR) and utilization 2025 open enrollment / ACA market growth SG&A leverage and operating efficiency
Revenue
$2.42B
▲ 68.3% YoY
Diluted EPS
$-0.22
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-07
Oscar Health, Inc. (OSCR) Q2 2024 Earnings Call Transcript
Confident tone Medical loss ratio / medical costs 2025 and rate filings ACA / enhanced subsidies
Revenue
$2.22B
▲ 45.9% YoY
Diluted EPS
$0.20
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
Oscar Health, Inc. (OSCR) Q1 2024 Earnings Call Transcript
Confident tone Medical Loss Ratio Membership Growth Profitability and Net Income Milestone
Revenue
$2.14B
▲ 45.8% YoY
Diluted EPS
$0.62
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-07
Oscar Health, Inc. (OSCR) Q4 2023 Earnings Call Transcript
Confident tone Open enrollment and membership growth Medical loss ratio improvement Member experience and NPS
Revenue
$1.43B*
▲ 43.9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-07
Oscar Health, Inc. (OSCR) Q3 2023 Earnings Call Transcript
Revenue
$1.44B
▲ 47.2% YoY
Diluted EPS
$-0.29
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-08
Oscar Health, Inc. (OSCR) Q2 2023 Earnings Call Transcript
Revenue
$1.52B
▲ 49.6% YoY
Diluted EPS
$-0.07
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
Oscar Health, Inc. (OSCR) Q1 2023 Earnings Call Transcript
Revenue
$1.47B
▲ 51.1% YoY
Diluted EPS
$-0.18
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-09
Oscar Health, Inc. (OSCR) Q4 2022 Earnings Call Transcript
Revenue
$995.13M*
▲ 100.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-08
Oscar Health, Inc. (OSCR) Q3 2022 Earnings Call Transcript
Revenue
$978.43M
▲ 120.4% YoY
Diluted EPS
$-0.91
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-11
Oscar Health, Inc. (OSCR) Q2 2022 Earnings Call Transcript
Revenue
$1.02B
▲ 92.2% YoY
Diluted EPS
$-0.53
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-10
Oscar Health, Inc. (OSCR) Q1 2022 Earnings Call Transcript
Revenue
$972.76M
▲ 163.3% YoY
Diluted EPS
$-0.36
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-10
Oscar Health, Inc. (OSCR) Q4 2021 Earnings Call Transcript
Revenue
$496.07M*
▲ 214.6% YoY
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-10
Oscar Health, Inc. (OSCR) Q3 2021 Earnings Call Transcript
Revenue
$443.98M
▲ 336.6% YoY
Diluted EPS
$-1.02
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-12
Oscar Health, Inc. (OSCR) Q2 2021 Earnings Call Transcript
Revenue
$529.28M
▲ 358.9% YoY
Diluted EPS
$-0.35
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-13
Oscar Health, Inc. (OSCR) Q1 2021 Earnings Call Transcript
Revenue
$369.39M
▲ 319.3% YoY
Diluted EPS
$-1.00
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–24 of 24 webcasts
Key facts CIK 1568651 CUSIP 687793109 13F (30d) 335 filings 308 filers Visit website Investor relations